LDLT across ABO blood type has been introduced widely in Japan. 1 The cumulative patient survival rate in adult ABO-I LT has been successfully improved and comparable to that in ABO-compatible LT with the appearance of RTX prophylaxis. 1, 2 Infants are prone to tolerance induction without any desensitization protocol in pediatric LT because of their immature immunity.
| C A S E PRE S ENTATI ON
A 20-month-old girl with a history of hepatoportoenterostomy for BA was referred to our center for the indication of LT. She suffered from hyperbilirubinemia (18.8 mg/dL) and hepatopulmonary syndrome with a shunt ratio of 21% by lung perfusion scintigraphy with 99m Tc macroaggregated albumin. She underwent LT receiving a partial graft from her ABO-I mother (28 years old). The preoperative anti-donor blood type antibody titers were 1:128 with IgM and 1:8 with IgG ( Figure 1 ). The complement-dependent cytotoxic lymphocyte crossmatch test was negative before transplantation. Left lateral segment graft weighing 212 g with a graft-to-recipient body weight ratio of 2.1% was successfully transplanted. Tacrolimus and low-dose steroids were initiated as an institutional standard immunosuppression protocol. Anti-donor blood type antibody titers were measured as a surrogate marker for AMR daily after LT for the first 2 weeks and then twice a week afterward until discharge.
On POD 6, she developed high fever and liver dysfunction. Her serum total bilirubin level rose sharply to 6.9 mg/dL ( Figure 1 ). The Doppler ultrasound revealed abrupt decrease of portal venous flow into the graft. Antibody titers with IgM decreased once to 1:2 after LT and then rebounded to 1:16. We introduced different treatments, including steroid bolus injection followed by PE and IVIG, immediately One and a half years after LDLT, she suffered from repeated cholangitis due to IHBC, necessitating the management by PTBD ( Figure 4B ).
| Review of the outcomes of ABO-I pediatric LT at our center
We analyzed our own institutional database of patients treated when the value was <1:32% and 11.4% when it was 1:32 or more (P = 0.048). There were no specific cutoff values for the IgG titer to estimate AMR development preoperatively.
| D ISCUSS I ON
The diagnostic criteria of acute AMR in the liver graft consist of the histopathology and serum DSA. 6 In the setting of acute AMR caused by ABO-I organ transplantation, a diagnosis must be made rapidly in order to start treatment with an appropriate timing and protocol.
Rebound of the serum bilirubin level and DSA titer after transplantation may reflect early treatment introduction. 7 In the present case, however, despite the early initiation of treatments against combined rejection, the serum IgG titer rose to 1:128 with a delay in the IgM rebound, suggesting severe AMR. 8 Our treatment strategy to neutralize the antibody with IVIG and PE and suppress the T cell reaction by steroid bolus and ATG may be inefficient, necessitating a more effective treatment to reduce the antibody reaction.
The B cell count in peripheral blood lymphocyte is normally 22%-27% in infants and <10% after organ transplant. achieved comparable results to ABO-compatible transplantation and is now broadly used as desensitization therapy. 1 When performing desensitization therapy in children, it is necessary to consider their immature immunity, with the ability to produce antibodies remaining low until 2 years of age. 16 The Japanese registry for pediatric LT showed that the 5-year survival rate in ABO-I LT was better in children under 2 years of age than in those over 2 years of age.
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Within children under 2 years old, the UNOS registry showed no distinct differences in the cumulative survival rates between under 1 year old and over. 17 As such, it has been suggested that 2 years of age be used as the cutoff for the institution of desensitization therapy.
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Our review of our institutional database, including 79 cases of pediatric ABO-I LT, confirmed that there were no cases of AMR or IHBC during the first year of life, suggesting that RTX could be omitted in this age group. However, the development of IHBD caused by AMR in the other two cases between one-and twoyear-olds was previously reported. 4 In those cases, the preoperative antibody titers were over 1:128, and the IgM antibody titer rebounded at the onset of AMR (Table 2 ). Our institutional review also suggested that the preoperative IgM titer could be used as a surrogate marker to estimate AMR occurrence when it is 1:32 or more. This is consistent with the reports that a high preoperative antibody titer (1:64 or more IgG) is a risk factor for AMR in adult LT, 1 although a different class of immunoglobulin (IgM instead of IgG) was recognized as a potential surrogate marker in the current study.
The difference between IgM and IgG may be related to immune maturity. In childhood, the IgM titer rises with age and decreases in adulthood. In contrast, IgG has a low value in childhood and increases with age. 4 Preformed ABO blood type antigens are natural antibodies produced in infancy without T cell-mediated sensitization. While the natural antibodies have strong affinity for the ABO blood type antigens on the surface of erythrocytes, they are poorly reactive with the ABO histo-antigens on the vascular endothelial cells of grafts. 18 De novo antibodies, once produced by T cell-mediated sensitization post-transplant, show strong reactivity to the ABO histo-antigens and elicit acute AMR. The preoperative antibody titer may be a surrogate marker for predicting AMR in pediatric LT, but it is not involved directly in the development of acute AMR.
| CON CLUS ION
Although histopathology is the gold standard for diagnosing AMR, a FACS analysis of the peripheral lymphocytes may provide compensatory clinical data to diagnose AMR. We recommend extending RTX prophylaxis, with a single dose of 375 mg/m 2 per BSA 1 month prior to LDLT, to children under 2 years of age in order to prevent AMR, especially when they reach 1 year of age and have a preoperative IgM antibody titer of 1:32 or more.
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